About this trial
The BAD-GER study is a multicenter, prospective, three-arm observational study serving to validate a prognostic biomarker algorithm for mortality and hospital readmission; this algorithm will be developed through the retrospective analysis of Alzheimer's Disease and neurodegeneration biomarkers in an already available discovery cohort of 700 previously hospitalized geriatric patients.
Eligibility criteria
Qualifiers
Inpatients with one of the following diagnoses: ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis/meningitis
Disqualifiers
no informed consent
inpatients with diagnosis of major neurocognitive disorder according to DSM-5 criteria (2013)
Inpatients with one of the following diagnoses: ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis/meningitis
no informed consent
Trial design
Treatments tested in this trial
- collection of blood samples
Treatment groups
Sponsors and collaborators
Istituto Nazionale di Ricovero e Cura per Anziani
Lead sponsor
Ministry of Health, Italy
Collaborator
University of Salento
Collaborator
IRCCS Multimedica
Collaborator
Azienda Ospedaliera Universitaria Policlinico "G. Martino"
Collaborator